Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MLYS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Brian Taylor Slingsby Director | MLYS Mineralys Therapeutics, Inc. | Sale | 104,320 | $28.81 | $3.0M Sale | Form 4 ↗ |
| Sep 21, 2026 | Eric Warren Chief Commercial Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 7,438 | $28.12 | $209.2K Sale | Form 4 ↗ |
| Sep 15, 2026 | Daphne Karydas Director | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $28.58 | $85.7K Sale | Form 4 ↗ |
| Aug 21, 2026 | Eric Warren Chief Commercial Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 7,437 | $25.98 | $193.2K Sale | Form 4 ↗ |
| Aug 10, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,170 | $27.09 | $58.8K Sale | Form 4 ↗ |
| Jul 21, 2026 | Eric Warren Chief Commercial Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 7,438 | $26.87 | $199.9K Sale | Form 4 ↗ |
| Jul 17, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 416 | $26.53 | $11.0K Sale | Form 4 ↗ |
| Jul 15, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,349 | $26.61 | $168.9K Sale | Form 4 ↗ |
| Jul 13, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 10,700 | $27.24 | $291.5K Sale | Form 4 ↗ |
| Jul 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 14,058 | $27.58 | $387.7K Sale | Form 4 ↗ |
| Jul 9, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,171 | $30.30 | $65.8K Sale | Form 4 ↗ |
| Jun 30, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 17,000 | $26.82 | $455.9K Sale | Form 4 ↗ |
| Jun 30, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 58,000 | $25.94 | $1.5M Sale | Form 4 ↗ |
| Jun 26, 2026 | Eric Warren Chief Commercial Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 104,124 | $25.90 | $2.7M Sale | Form 4 ↗ |
| Jun 17, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 4,584 | $25.00 | $114.6K Sale | Form 4 ↗ |
| Jun 17, 2026 | Daphne Karydas Director | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $25.00 | $75.0K Sale | Form 4 ↗ |
| Jun 15, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 9,890 | $23.81 | $235.5K Sale | Form 4 ↗ |
| Jun 12, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,349 | $23.93 | $151.9K Sale | Form 4 ↗ |
| Jun 10, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,170 | $25.00 | $54.3K Sale | Form 4 ↗ |
| May 18, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 417 | $27.55 | $11.5K Sale | Form 4 ↗ |
| May 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 14,056 | $28.58 | $401.7K Sale | Form 4 ↗ |
| May 12, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,348 | $29.36 | $186.4K Sale | Form 4 ↗ |
| May 11, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,171 | $29.71 | $64.5K Sale | Form 4 ↗ |
| Apr 17, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 416 | $31.33 | $13.0K Sale | Form 4 ↗ |
| Apr 15, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,348 | $27.66 | $175.6K Sale | Form 4 ↗ |
| Apr 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 14,058 | $26.54 | $373.1K Sale | Form 4 ↗ |
| Apr 13, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 15,730 | $26.83 | $422.0K Sale | Form 4 ↗ |
| Apr 9, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,170 | $27.38 | $59.4K Sale | Form 4 ↗ |
| Mar 31, 2026 | Daphne Karydas Director | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $25.00 | $75.0K Sale | Form 4 ↗ |
| Mar 31, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 453 | $27.05 | $12.3K Sale | Form 4 ↗ |
| Mar 31, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 55,183 | $26.54 | $1.5M Sale | Form 4 ↗ |
| Mar 31, 2026 | Jon Congleton Chief Executive Officer, Director | MLYS Mineralys Therapeutics, Inc. | Sale | 19,364 | $25.50 | $493.8K Sale | Form 4 ↗ |
| Mar 30, 2026 | Rajeev M. Shah Director | MLYS Mineralys Therapeutics, Inc. | Buy | 58,300 | $24.16 | $1.4M Buy | Form 4 ↗ |
| Mar 27, 2026 | Rajeev M. Shah Director | MLYS Mineralys Therapeutics, Inc. | Buy | 310,700 | $23.67 | $7.4M Buy | Form 4 ↗ |
| Mar 17, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 417 | $25.65 | $10.7K Sale | Form 4 ↗ |
| Mar 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 253 | $27.82 | $7,038 Sale | Form 4 ↗ |
| Mar 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 3,079 | $27.37 | $84.3K Sale | Form 4 ↗ |
| Mar 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 10,726 | $25.91 | $277.9K Sale | Form 4 ↗ |
| Mar 12, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,348 | $27.37 | $173.7K Sale | Form 4 ↗ |
| Mar 9, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,171 | $26.84 | $58.3K Sale | Form 4 ↗ |
| Feb 17, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 417 | $27.59 | $11.5K Sale | Form 4 ↗ |
| Feb 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 6,348 | $27.58 | $175.1K Sale | Form 4 ↗ |
| Feb 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 4,166 | $27.33 | $113.9K Sale | Form 4 ↗ |
| Feb 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 3,541 | $27.33 | $96.8K Sale | Form 4 ↗ |
| Feb 12, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 521 | $29.64 | $15.4K Sale | Form 4 ↗ |
| Feb 12, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 5,828 | $28.94 | $168.7K Sale | Form 4 ↗ |
| Feb 9, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 2,171 | $30.21 | $65.6K Sale | Form 4 ↗ |
| Jan 20, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 416 | $32.10 | $13.4K Sale | Form 4 ↗ |
| Jan 14, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 11,367 | $32.61 | $370.7K Sale | Form 4 ↗ |
| Jan 13, 2026 | David Malcom Rodman Chief Medical Officer | MLYS Mineralys Therapeutics, Inc. | Sale | 7,709 | $32.75 | $252.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances